Raffaele Ferrari1, Dena G Hernandez2, Michael A Nalls3, Jonathan D Rohrer4, Adaikalavan Ramasamy5, John B J Kwok6, Carol Dobson-Stone6, William S Brooks6, Peter R Schofield6, Glenda M Halliday6, John R Hodges6, Olivier Piguet6, Lauren Bartley7, Elizabeth Thompson8, Eric Haan8, Isabel Hernández9, Agustín Ruiz9, Mercè Boada10, Barbara Borroni11, Alessandro Padovani11, Carlos Cruchaga12, Nigel J Cairns13, Luisa Benussi14, Giuliano Binetti14, Roberta Ghidoni15, Gianluigi Forloni16, Daniela Galimberti17, Chiara Fenoglio17, Maria Serpente17, Elio Scarpini17, Jordi Clarimón18, Alberto Lleó18, Rafael Blesa18, Maria Landqvist Waldö19, Karin Nilsson19, Christer Nilsson20, Ian R A Mackenzie21, Ging-Yuek R Hsiung22, David M A Mann23, Jordan Grafman24, Christopher M Morris25, Johannes Attems26, Timothy D Griffiths27, Ian G McKeith28, Alan J Thomas29, P Pietrini30, Edward D Huey31, Eric M Wassermann32, Atik Baborie33, Evelyn Jaros34, Michael C Tierney32, Pau Pastor35, Cristina Razquin36, Sara Ortega-Cubero37, Elena Alonso36, Robert Perneczky38, Janine Diehl-Schmid39, Panagiotis Alexopoulos39, Alexander Kurz39, Innocenzo Rainero40, Elisa Rubino40, Lorenzo Pinessi40, Ekaterina Rogaeva41, Peter St George-Hyslop42, Giacomina Rossi43, Fabrizio Tagliavini43, Giorgio Giaccone43, James B Rowe44, Johannes C M Schlachetzki45, James Uphill46, John Collinge46, Simon Mead46, Adrian Danek47, Vivianna M Van Deerlin48, Murray Grossman48, John Q Trojanowski48, Julie van der Zee49, William Deschamps49, Tim Van Langenhove49, Marc Cruts49, Christine Van Broeckhoven49, Stefano F Cappa50, Isabelle Le Ber51, Didier Hannequin52, Véronique Golfier53, Martine Vercelletto54, Alexis Brice51, Benedetta Nacmias55, Sandro Sorbi55, Silvia Bagnoli55, Irene Piaceri55, Jørgen E Nielsen56, Lena E Hjermind56, Matthias Riemenschneider57, Manuel Mayhaus58, Bernd Ibach59, Gilles Gasparoni58, Sabrina Pichler58, Wei Gu60, Martin N Rossor61, Nick C Fox61, Jason D Warren61, Maria Grazia Spillantini62, Huw R Morris63, Patrizia Rizzu64, Peter Heutink64, Julie S Snowden65, Sara Rollinson65, Anna Richardson66, Alexander Gerhard67, Amalia C Bruni68, Raffaele Maletta68, Francesca Frangipane68, Chiara Cupidi68, Livia Bernardi68, Maria Anfossi68, Maura Gallo68, Maria Elena Conidi68, Nicoletta Smirne68, Rosa Rademakers69, Matt Baker69, Dennis W Dickson69, Neill R Graff-Radford70, Ronald C Petersen71, David Knopman71, Keith A Josephs71, Bradley F Boeve71, Joseph E Parisi72, William W Seeley73, Bruce L Miller73, Anna M Karydas73, Howard Rosen73, John C van Swieten74, Elise G P Dopper75, Harro Seelaar75, Yolande A L Pijnenburg76, Philip Scheltens76, Giancarlo Logroscino77, Rosa Capozzo77, Valeria Novelli78, Annibale A Puca79, Massimo Franceschi80, Alfredo Postiglione81, Graziella Milan82, Paolo Sorrentino82, Mark Kristiansen83, Huei-Hsin Chiang84, Caroline Graff84, Florence Pasquier85, Adeline Rollin85, Vincent Deramecourt85, Florence Lebert85, Dimitrios Kapogiannis86, Luigi Ferrucci87, Stuart Pickering-Brown65, Andrew B Singleton3, John Hardy88, Parastoo Momeni89. 1. Laboratory of Neurogenetics, Department of Internal Medicine, Texas Tech University Health Science Center, Lubbock, Texas, USA; Reta Lila Weston Research Laboratories, Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK. 2. Reta Lila Weston Research Laboratories, Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK; Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA. 3. Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA. 4. Reta Lila Weston Research Laboratories, Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK; Dementia Research Centre, Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, UK. 5. Reta Lila Weston Research Laboratories, Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK; Department of Medical and Molecular Genetics, King's College London, Guy's Hospital, London, UK. 6. Neuroscience Research Australia, Sydney, NSW, Australia; University of New South Wales, Sydney, NSW, Australia. 7. Neuroscience Research Australia, Sydney, NSW, Australia. 8. South Australian Clinical Genetics Service, SA Pathology at Women's and Children's Hospital, North Adelaide, SA, Australia; Department of Paediatrics, University of Adelaide, Adelaide, SA, Australia. 9. Memory Clinic of Fundació ACE, Institut Català de Neurociències Aplicades, Barcelona, Spain. 10. Memory Clinic of Fundació ACE, Institut Català de Neurociències Aplicades, Barcelona, Spain; Hospital Universitari Vall d'Hebron-Institut de Recerca, Universitat Autonoma de Barcelona (VHIR-UAB), Barcelona, Spain. 11. Neurology Clinic, University of Brescia, Brescia, Italy. 12. Department of Psychiatry, Washington University School of Medicine, St Louis, Missouri, USA; Hope Center, Washington University School of Medicine, St Louis, Missouri, USA. 13. Hope Center, Washington University School of Medicine, St Louis, Missouri, USA; Department of Pathology and Immunology, Washington University, St Louis, Missouri, USA. 14. NeuroBioGen Lab-Memory Clinic, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy. 15. Proteomics Unit, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy. 16. Biology of Neurodegenerative Disorders, IRCCS Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy. 17. University of Milan, Milan, Italy; Fondazione Cà Granda, IRCCS Ospedale Maggiore Policlinico, Milan, Italy. 18. Memory Unit, Neurology Department and Sant Pau Biomedical Research Institute, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain; Center for Networker Biomedical Research in Neurodegenerative Diseases (CIBERNED), Madrid, Spain. 19. Unit of Geriatric Psychiatry, Department of Clinical Sciences, Lund University, Sweden. 20. Clinical Memory Research Unit, Department of Clinical Sciences, Lund University, Sweden. 21. Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada. 22. Division of Neurology, University of British Columbia, Vancouver, Canada. 23. Institute of Brain, Behaviour and Mental Health, University of Manchester, Salford Royal Hospital, Stott Lane, Salford, UK. 24. Rehabilitation Institute of Chicago, Departments of Physical Medicine and Rehabilitation, Psychiatry, and Cognitive Neurology and Alzheimer's Disease Center, IL, USA; Feinberg School of Medicine, Northwestern University, IL, USA; Department of Psychology, Weinberg College of Arts and Sciences, Northwestern University, IL, USA. 25. Rehabilitation Institute of Chicago, Departments of Physical Medicine and Rehabilitation, Psychiatry, and Cognitive Neurology and Alzheimer's Disease Center, IL, USA; Feinberg School of Medicine, Northwestern University, IL, USA; Newcastle Brain Tissue Resource, Institute for Ageing and Health, Newcastle University, Newcastle upon Tyne, UK; Newcastle University, Institute for Ageing and Health, Campus for Ageing and Vitality, Newcastle upon Tyne, UK; Institute of Neuroscience, Newcastle University Medical School, Newcastle upon Tyne, UK. 26. Rehabilitation Institute of Chicago, Departments of Physical Medicine and Rehabilitation, Psychiatry, and Cognitive Neurology and Alzheimer's Disease Center, IL, USA; Feinberg School of Medicine, Northwestern University, IL, USA; Newcastle Brain Tissue Resource, Institute for Ageing and Health, Newcastle University, Newcastle upon Tyne, UK; Newcastle University, Institute for Ageing and Health, Campus for Ageing and Vitality, Newcastle upon Tyne, UK. 27. Rehabilitation Institute of Chicago, Departments of Physical Medicine and Rehabilitation, Psychiatry, and Cognitive Neurology and Alzheimer's Disease Center, IL, USA; Feinberg School of Medicine, Northwestern University, IL, USA; Newcastle Brain Tissue Resource, Institute for Ageing and Health, Newcastle University, Newcastle upon Tyne, UK; Institute of Neuroscience, Newcastle University Medical School, Newcastle upon Tyne, UK. 28. Biomedical Research Building, Campus for Ageing and Vitality, Newcastle University, Newcastle upon Tyne, UK. 29. Newcastle University, Institute for Ageing and Health, Campus for Ageing and Vitality, Newcastle upon Tyne, UK. 30. Clinical Psychology Branch, Pisa University Hospital, Pisa, Italy; Laboratory of Clinical Biochemistry and Molecular Biology, University of Pisa, Pisa, Italy. 31. Taub Institute, Departments of Psychiatry and Neurology, Columbia University, New York, NY, USA 10032. 32. Behavioral Neurology Unit, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA. 33. Neuropathology Department, Walton Centre FT, Liverpool, UK. 34. Newcastle University, Institute for Ageing and Health, Campus for Ageing and Vitality, Newcastle upon Tyne, UK; Neuropathology/Cellular Pathology, Royal Victoria Infirmary, Newcastle upon Tyne, UK. 35. Center for Networker Biomedical Research in Neurodegenerative Diseases (CIBERNED), Madrid, Spain; Neurogenetics Laboratory, Division of Neurosciences, Center for Applied Medical Research, Universidad de Navarra, Pamplona, Spain; Department of Neurology, Clínica Universidad de Navarra, University of Navarra School of Medicine, Pamplona, Spain. 36. Neurogenetics Laboratory, Division of Neurosciences, Center for Applied Medical Research, Universidad de Navarra, Pamplona, Spain. 37. Center for Networker Biomedical Research in Neurodegenerative Diseases (CIBERNED), Madrid, Spain; Neurogenetics Laboratory, Division of Neurosciences, Center for Applied Medical Research, Universidad de Navarra, Pamplona, Spain. 38. Neuroepidemiology and Ageing Research Unit, School of Public Health, Faculty of Medicine, The Imperial College of Science, Technology and Medicine, London, UK; West London Cognitive Disorders Treatment and Research Unit, West London Mental Health Trust, London TW8 8 DS, UK; Department of Psychiatry and Psychotherapy, Technische Universität München, Munich, Germany. 39. Department of Psychiatry and Psychotherapy, Technische Universität München, Munich, Germany. 40. Neurology I, Department of Neuroscience, University of Torino, Italy; AO Città della Salute e della Scienza di Torino, Italy. 41. Tanz Centre for Research in Neurodegenerative Diseases and Department of Medicine, University of Toronto, Toronto, Ontario, Canada. 42. Tanz Centre for Research in Neurodegenerative Diseases and Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Cambridge Institute for Medical Research and the Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK. 43. Division of Neurology V and Neuropathology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano, Italy. 44. Cambridge University Department of Clinical Neurosciences, Cambridge CB2 0SZ, UK; MRC Cognition and Brain Sciences Unit, Cambridge, UK; Behavioural and Clinical Neuroscience Institute, Cambridge, UK. 45. Department of Psychiatry and Psychotherapy, University of Freiburg Medical School, Germany; Department of Molecular Neurology, University Hospital Erlangen, Erlangen, Germany. 46. MRC Prion Unit, Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK. 47. Neurologische Klinik und Poliklinik, Ludwig-Maximilians-Universität, Munich, Germany; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany. 48. University of Pennsylvania Perelman School of Medicine, Department of Neurology and Penn Frontotemporal Degeneration Center, Philadelphia, PA, USA. 49. Neurodegenerative Brain Diseases group, Department of Molecular Genetics, VIB, Antwerp, Belgium; Laboratory of Neurogenetics, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium. 50. Neurorehabilitation Unit, Deptartment Of Clinical Neuroscience, Vita-Salute University and San Raffaele Scientific Institute, Milan, Italy. 51. Inserm, UMR_S975, CRICM, F-75013; UPMC Univ Paris 06, UMR_S975, F-75013; and CNRS UMR 7225, F-75013, Paris, France; AP-HP, Hôpital de la Salpêtrière, Département de Neurologie-Centre de Références des Démences Rares, F-75013, Paris, France. 52. Service de Neurologie, Inserm U1079, CNR-MAJ, Rouen University Hospital, France. 53. Service de neurologie, CH Saint Brieuc, France. 54. Service de Neurologie, CHU Nantes, France. 55. Department of Neurosciences, Psychology, Drug Research and Child Health (NEUROFARBA) University of Florence, Florence, Italy. 56. Danish Dementia Research Centre, Neurogenetics Clinic, Department of Neurology, Rigshospitalet, Copenhagen University Hospital, Denmark; Department of Cellular and Molecular Medicine, Section of Neurogenetics, The Panum Institute, University of Copenhagen, Denmark. 57. Saarland University Hospital, Department for Psychiatry and Psychotherapy, Homburg/Saar, Germany; Saarland University, Laboratory for Neurogenetics, Kirrberger, Homburg/Saar, Germany. 58. Saarland University, Laboratory for Neurogenetics, Kirrberger, Homburg/Saar, Germany. 59. University Regensburg, Department of Psychiatry, Psychotherapy and Psychosomatics, Universitätsstr 84, Regensburg, Germany. 60. Saarland University, Laboratory for Neurogenetics, Kirrberger, Homburg/Saar, Germany; Luxembourg Centre For Systems Biomedicine (LCSB), University of Luxembourg, Luxembourg. 61. Dementia Research Centre, Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, UK. 62. University of Cambridge, Department of Clinical Neurosciences, John Van Geest Brain Repair Centre, Cambridge, UK. 63. MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, School of Medicine, Cardiff, UK. 64. German Center of Neurodegenerative Diseases-Tübingen, Tübingen, Germany. 65. Institute of Brain, Behaviour and Mental Health, Faculty of Medical and Human Sciences, University of Manchester, Manchester, UK. 66. Salford Royal Foundation Trust, Faculty of Medical and Human Sciences, University of Manchester, UK. 67. Institute of Brain, Behaviour and Mental Health, The University of Manchester, Withington, Manchester, UK. 68. Regional Neurogenetic Centre, ASPCZ, Lamezia Terme, Italy. 69. Department of Neuroscience, Mayo Clinic Jacksonville, Jacksonville, FL, USA. 70. Department of Neurology, Mayo Clinic Jacksonville, Jacksonville, FL, USA. 71. Department of Neurology, Mayo Clinic Rochester, Rochester, MN, USA. 72. Department of Pathology, Mayo Clinic Rochester, Rochester, MN, USA. 73. Department of Neurology, University of California, San Francisco, CA, USA. 74. Department of Neurology, Erasmus Medical Centre, Rotterdam, The Netherlands; Department of Medical Genetics, VU University Medical Centre, Amsterdam, The Netherlands. 75. Department of Neurology, Erasmus Medical Centre, Rotterdam, The Netherlands. 76. Alzheimer Centre and Department of Neurology, VU University Medical Centre, Amsterdam, The Netherlands. 77. Department of Basic Medical Sciences, Neurosciences and Sense Organs of the Aldo Moro, University of Bari, Italy. 78. Department of Molecular Cardiology, IRCCS Fondazione S Maugeri, Pavia, Italy. 79. Cardiovascular Research Unit, IRCCS Multimedica, Milan, Italy; Department of Medicine and Surgery, University of Salerno, Baronissi (SA), Italy. 80. Neurology Department, IRCCS Multimedica, Milan, Italy. 81. Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy. 82. Geriatric Center Frullone-ASL Napoli 1 Centro, Naples, Italy. 83. UCL Genomics, Institute of Child Health (ICH), UCL, London, UK. 84. Karolinska Institutet, Department NVS, KI-Alzheimer Disease Research Center, Stockholm, Sweden; Department of Geriatric Medicine, Genetics Unit, Karolinska Universtiy Hospital, Stockholm. 85. Université Lille Nord de France, Lille, France. 86. Laboratory of Neurosciences, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA. 87. Clinical Research Branch, National Institute on Aging, Baltimore, MD, USA. 88. Reta Lila Weston Research Laboratories, Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK. Electronic address: j.hardy@ucl.ac.uk. 89. Laboratory of Neurogenetics, Department of Internal Medicine, Texas Tech University Health Science Center, Lubbock, Texas, USA.
Abstract
BACKGROUND: Frontotemporal dementia (FTD) is a complex disorder characterised by a broad range of clinical manifestations, differential pathological signatures, and genetic variability. Mutations in three genes-MAPT, GRN, and C9orf72--have been associated with FTD. We sought to identify novel genetic risk loci associated with the disorder. METHODS: We did a two-stage genome-wide association study on clinical FTD, analysing samples from 3526 patients with FTD and 9402 healthy controls. To reduce genetic heterogeneity, all participants were of European ancestry. In the discovery phase (samples from 2154 patients with FTD and 4308 controls), we did separate association analyses for each FTD subtype (behavioural variant FTD, semantic dementia, progressive non-fluent aphasia, and FTD overlapping with motor neuron disease [FTD-MND]), followed by a meta-analysis of the entire dataset. We carried forward replication of the novel suggestive loci in an independent sample series (samples from 1372 patients and 5094 controls) and then did joint phase and brain expression and methylation quantitative trait loci analyses for the associated (p<5 × 10(-8)) single-nucleotide polymorphisms. FINDINGS: We identified novel associations exceeding the genome-wide significance threshold (p<5 × 10(-8)). Combined (joint) analyses of discovery and replication phases showed genome-wide significant association at 6p21.3, HLA locus (immune system), for rs9268877 (p=1·05 × 10(-8); odds ratio=1·204 [95% CI 1·11-1·30]), rs9268856 (p=5·51 × 10(-9); 0·809 [0·76-0·86]) and rs1980493 (p value=1·57 × 10(-8), 0·775 [0·69-0·86]) in the entire cohort. We also identified a potential novel locus at 11q14, encompassing RAB38/CTSC (the transcripts of which are related to lysosomal biology), for the behavioural FTD subtype for which joint analyses showed suggestive association for rs302668 (p=2·44 × 10(-7); 0·814 [0·71-0·92]). Analysis of expression and methylation quantitative trait loci data suggested that these loci might affect expression and methylation in cis. INTERPRETATION: Our findings suggest that immune system processes (link to 6p21.3) and possibly lysosomal and autophagy pathways (link to 11q14) are potentially involved in FTD. Our findings need to be replicated to better define the association of the newly identified loci with disease and to shed light on the pathomechanisms contributing to FTD. FUNDING: The National Institute of Neurological Disorders and Stroke and National Institute on Aging, the Wellcome/MRC Centre on Parkinson's disease, Alzheimer's Research UK, and Texas Tech University Health Sciences Center.
BACKGROUND: Frontotemporal dementia (FTD) is a complex disorder characterised by a broad range of clinical manifestations, differential pathological signatures, and genetic variability. Mutations in three genes-MAPT, GRN, and C9orf72--have been associated with FTD. We sought to identify novel genetic risk loci associated with the disorder. METHODS: We did a two-stage genome-wide association study on clinical FTD, analysing samples from 3526 patients with FTD and 9402 healthy controls. To reduce genetic heterogeneity, all participants were of European ancestry. In the discovery phase (samples from 2154 patients with FTD and 4308 controls), we did separate association analyses for each FTD subtype (behavioural variant FTD, semantic dementia, progressive non-fluent aphasia, and FTD overlapping with motor neuron disease [FTD-MND]), followed by a meta-analysis of the entire dataset. We carried forward replication of the novel suggestive loci in an independent sample series (samples from 1372 patients and 5094 controls) and then did joint phase and brain expression and methylation quantitative trait loci analyses for the associated (p<5 × 10(-8)) single-nucleotide polymorphisms. FINDINGS: We identified novel associations exceeding the genome-wide significance threshold (p<5 × 10(-8)). Combined (joint) analyses of discovery and replication phases showed genome-wide significant association at 6p21.3, HLA locus (immune system), for rs9268877 (p=1·05 × 10(-8); odds ratio=1·204 [95% CI 1·11-1·30]), rs9268856 (p=5·51 × 10(-9); 0·809 [0·76-0·86]) and rs1980493 (p value=1·57 × 10(-8), 0·775 [0·69-0·86]) in the entire cohort. We also identified a potential novel locus at 11q14, encompassing RAB38/CTSC (the transcripts of which are related to lysosomal biology), for the behavioural FTD subtype for which joint analyses showed suggestive association for rs302668 (p=2·44 × 10(-7); 0·814 [0·71-0·92]). Analysis of expression and methylation quantitative trait loci data suggested that these loci might affect expression and methylation in cis. INTERPRETATION: Our findings suggest that immune system processes (link to 6p21.3) and possibly lysosomal and autophagy pathways (link to 11q14) are potentially involved in FTD. Our findings need to be replicated to better define the association of the newly identified loci with disease and to shed light on the pathomechanisms contributing to FTD. FUNDING: The National Institute of Neurological Disorders and Stroke and National Institute on Aging, the Wellcome/MRC Centre on Parkinson's disease, Alzheimer's Research UK, and Texas Tech University Health Sciences Center.
Authors: Richard B Roth; Peter Hevezi; Jerry Lee; Dorian Willhite; Sandra M Lechner; Alan C Foster; Albert Zlotnik Journal: Neurogenetics Date: 2006-03-30 Impact factor: 2.660
Authors: D Neary; J S Snowden; L Gustafson; U Passant; D Stuss; S Black; M Freedman; A Kertesz; P H Robert; M Albert; K Boone; B L Miller; J Cummings; D F Benson Journal: Neurology Date: 1998-12 Impact factor: 9.910
Authors: Marc Cruts; Ilse Gijselinck; Julie van der Zee; Sebastiaan Engelborghs; Hans Wils; Daniel Pirici; Rosa Rademakers; Rik Vandenberghe; Bart Dermaut; Jean-Jacques Martin; Cornelia van Duijn; Karin Peeters; Raf Sciot; Patrick Santens; Tim De Pooter; Maria Mattheijssens; Marleen Van den Broeck; Ivy Cuijt; Krist'l Vennekens; Peter P De Deyn; Samir Kumar-Singh; Christine Van Broeckhoven Journal: Nature Date: 2006-07-16 Impact factor: 49.962
Authors: Tanja Zeller; Philipp Wild; Silke Szymczak; Maxime Rotival; Arne Schillert; Raphaele Castagne; Seraya Maouche; Marine Germain; Karl Lackner; Heidi Rossmann; Medea Eleftheriadis; Christoph R Sinning; Renate B Schnabel; Edith Lubos; Detlev Mennerich; Werner Rust; Claire Perret; Carole Proust; Viviane Nicaud; Joseph Loscalzo; Norbert Hübner; David Tregouet; Thomas Münzel; Andreas Ziegler; Laurence Tiret; Stefan Blankenberg; François Cambien Journal: PLoS One Date: 2010-05-18 Impact factor: 3.240
Authors: Sudha Seshadri; Annette L Fitzpatrick; M Arfan Ikram; Anita L DeStefano; Vilmundur Gudnason; Merce Boada; Joshua C Bis; Albert V Smith; Minerva M Carassquillo; Jean Charles Lambert; Denise Harold; Elisabeth M C Schrijvers; Reposo Ramirez-Lorca; Stephanie Debette; W T Longstreth; A Cecile J W Janssens; V Shane Pankratz; Jean François Dartigues; Paul Hollingworth; Thor Aspelund; Isabel Hernandez; Alexa Beiser; Lewis H Kuller; Peter J Koudstaal; Dennis W Dickson; Christophe Tzourio; Richard Abraham; Carmen Antunez; Yangchun Du; Jerome I Rotter; Yurii S Aulchenko; Tamara B Harris; Ronald C Petersen; Claudine Berr; Michael J Owen; Jesus Lopez-Arrieta; Badri N Varadarajan; James T Becker; Fernando Rivadeneira; Michael A Nalls; Neill R Graff-Radford; Dominique Campion; Sanford Auerbach; Kenneth Rice; Albert Hofman; Palmi V Jonsson; Helena Schmidt; Mark Lathrop; Thomas H Mosley; Rhoda Au; Bruce M Psaty; Andre G Uitterlinden; Lindsay A Farrer; Thomas Lumley; Agustin Ruiz; Julie Williams; Philippe Amouyel; Steve G Younkin; Philip A Wolf; Lenore J Launer; Oscar L Lopez; Cornelia M van Duijn; Monique M B Breteler Journal: JAMA Date: 2010-05-12 Impact factor: 56.272
Authors: Adaikalavan Ramasamy; Daniah Trabzuni; J Raphael Gibbs; Allissa Dillman; Dena G Hernandez; Sampath Arepalli; Robert Walker; Colin Smith; Gigaloluwa Peter Ilori; Andrey A Shabalin; Yun Li; Andrew B Singleton; Mark R Cookson; John Hardy; Mina Ryten; Michael E Weale Journal: Nucleic Acids Res Date: 2013-02-21 Impact factor: 16.971
Authors: Nuno L Barbosa-Morais; Mark J Dunning; Shamith A Samarajiwa; Jeremy F J Darot; Matthew E Ritchie; Andy G Lynch; Simon Tavaré Journal: Nucleic Acids Res Date: 2009-11-18 Impact factor: 16.971
Authors: Michael J Hawrylycz; Ed S Lein; Angela L Guillozet-Bongaarts; Elaine H Shen; Lydia Ng; Jeremy A Miller; Louie N van de Lagemaat; Kimberly A Smith; Amanda Ebbert; Zackery L Riley; Chris Abajian; Christian F Beckmann; Amy Bernard; Darren Bertagnolli; Andrew F Boe; Preston M Cartagena; M Mallar Chakravarty; Mike Chapin; Jimmy Chong; Rachel A Dalley; Barry David Daly; Chinh Dang; Suvro Datta; Nick Dee; Tim A Dolbeare; Vance Faber; David Feng; David R Fowler; Jeff Goldy; Benjamin W Gregor; Zeb Haradon; David R Haynor; John G Hohmann; Steve Horvath; Robert E Howard; Andreas Jeromin; Jayson M Jochim; Marty Kinnunen; Christopher Lau; Evan T Lazarz; Changkyu Lee; Tracy A Lemon; Ling Li; Yang Li; John A Morris; Caroline C Overly; Patrick D Parker; Sheana E Parry; Melissa Reding; Joshua J Royall; Jay Schulkin; Pedro Adolfo Sequeira; Clifford R Slaughterbeck; Simon C Smith; Andy J Sodt; Susan M Sunkin; Beryl E Swanson; Marquis P Vawter; Derric Williams; Paul Wohnoutka; H Ronald Zielke; Daniel H Geschwind; Patrick R Hof; Stephen M Smith; Christof Koch; Seth G N Grant; Allan R Jones Journal: Nature Date: 2012-09-20 Impact factor: 49.962
Authors: Yann Wan Yap; Roxana M Llanos; Sharon La Fontaine; Michael A Cater; Philip M Beart; Nam Sang Cheung Journal: Neurochem Res Date: 2015-08-29 Impact factor: 3.996
Authors: Lars M Ittner; Glenda M Halliday; Jillian J Kril; Jürgen Götz; John R Hodges; Matthew C Kiernan Journal: Nat Rev Neurol Date: 2015-05-05 Impact factor: 42.937
Authors: Shubhabrata Mukherjee; Joshua C Russell; Daniel T Carr; Jeremy D Burgess; Mariet Allen; Daniel J Serie; Kevin L Boehme; John S K Kauwe; Adam C Naj; David W Fardo; Dennis W Dickson; Thomas J Montine; Nilufer Ertekin-Taner; Matt R Kaeberlein; Paul K Crane Journal: Alzheimers Dement Date: 2017-02-24 Impact factor: 21.566
Authors: Raffaele Ferrari; Yunpeng Wang; Jana Vandrovcova; Sebastian Guelfi; Aree Witeolar; Celeste M Karch; Andrew J Schork; Chun C Fan; James B Brewer; Parastoo Momeni; Gerard D Schellenberg; William P Dillon; Leo P Sugrue; Christopher P Hess; Jennifer S Yokoyama; Luke W Bonham; Gil D Rabinovici; Bruce L Miller; Ole A Andreassen; Anders M Dale; John Hardy; Rahul S Desikan Journal: J Neurol Neurosurg Psychiatry Date: 2016-11-29 Impact factor: 10.154
Authors: Jennifer S Yokoyama; Celeste M Karch; Chun C Fan; Luke W Bonham; Naomi Kouri; Owen A Ross; Rosa Rademakers; Jungsu Kim; Yunpeng Wang; Günter U Höglinger; Ulrich Müller; Raffaele Ferrari; John Hardy; Parastoo Momeni; Leo P Sugrue; Christopher P Hess; A James Barkovich; Adam L Boxer; William W Seeley; Gil D Rabinovici; Howard J Rosen; Bruce L Miller; Nicholas J Schmansky; Bruce Fischl; Bradley T Hyman; Dennis W Dickson; Gerard D Schellenberg; Ole A Andreassen; Anders M Dale; Rahul S Desikan Journal: Acta Neuropathol Date: 2017-03-07 Impact factor: 17.088